✦ LIBER ✦

Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib

✍ Scribed by Whi-An Kwon MD,In-Chang Cho MD,Ami Yu PhD,Byung-Ho Nam MD…

Book ID: 126394290
Publisher: Springer
Year: 2013
Tongue: English
Weight: 377 KB
Volume: 20
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3290-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Choi response criteria for prediction of

Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies

✍ Noemi Schmidt, Viviane Hess, Thomas Zumbrunn, Christian Rothermundt… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 524 KB

Choi response criteria for early predict

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

✍ van der Veldt, A A M; Meijerink, M R; van den Eertwegh, A J M; Haanen, J B A G; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 447 KB

Predictive role of tissue-based molecula

Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma

✍ You, Dalsan; Song, Sang Hoon; Cho, Yong Mee; Lee, Jae-Lyun; Jeong, In Gab; Song, 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 231 KB

The impact of tumor burden characteristi

The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib

✍ Naveen S. Basappa; Paul Elson; Ali-Reza Golshayan; Laura Wood; Jorge A. Garcia; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

984 Potential predictive markers for a r

984 Potential predictive markers for a response to sunitinib and their association with survival of patients with metastatic renal cell carcinoma

✍ Dornbusch, J.; Meinhardt, M.; Erdmann, K.; Zacharis, A.; Zastrow, S.; Füssel, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Overall Survival and Updated Results for

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

✍ Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; O 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 186 KB